Jamaica Hospital Medical Center Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2005
NCT00374348
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

Department of Psychiatry, Jamaica Hospital Medical Center

Active Ingredients

Drugs in Phase 3 Trials (3)

bupivacaine (Exparel) (1 trial)

levobupivacaine (chirocaine) (1 trial)

sertaconazole (ertaczo) (1 trial)

Drugs in Other Trials (1)

aripiprazole (abilify) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Ankle Fractures (Phase 3)

Fractures, Bone (Phase 3)

Tinea (Phase 3)

Tinea Pedis (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 4